Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.10 | N/A |
PEG Ratio (TTM) | 0.00 | N/A |
P/S Ratio (TTM) | 0.45 | N/A |
P/B Ratio (TTM) | 0.01 | N/A |
P/FCF Ratio (TTM) | -0.16 | N/A |
Price to 5YR AVG Earnings Ratio | -0.03 | N/A |
Price to 5YR AVG FCF Ratio | -0.34 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -6.36% | N/A |
ROE (TTM) | -16.11% | N/A |
Net Profit Margin (TTM) | -31.75% | N/A |
ROIC 5YR AVG | -62.14% | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | N/A | -11.83% | -59.54% |
Revenue | N/A | -9.29% | -8.70% |
Net Income | N/A | -11.96% | -59.01% |
Cash Flow | N/A | -230.87% | -278.56% |
Health (51%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.12 | N/A |
Quick Ratio (TTM) | 2.08 | N/A |
D/E Ratio (TTM) | 0.15 | N/A |
Interest Coverage (TTM) | N/A | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -0.97 | N/A |
Shares Outstanding Growth 5YR AVG | -0.25% | N/A |